Save stories to read later or create you own news web site to share with anyone
Notify me when I can create my custom news board
We will not share your email addressAlready on AllSides? Log In
AllSides members can bookmark any article and read it later. Save this article by becoming a member today!
Join AllSides to read, share and understand all perspectives of today's news and issues.
Learn more »AllSides members can instantly post news stories to their own personal page, making it easy to share and discuss information they care about. Become your own publisher by becoming a member today! Learn about My Front Page.
Join AllSides to read, share and understand all perspectives of today's news and issues.
Learn more »A week after the FDA approved the Pfizer/BioNTech coronavirus vaccine for emergency use, the agency has granted the same approval for Moderna's vaccine. In clinical trials, Moderna's candidate was over 94 percent effective.
On Thursday night, the Vaccines and Related Biological Products Advisory Committee voted 20-0 to recommend the vaccine be made available.
"The evidence that has been studied in great detail on this vaccine highly outweighs any of the issues we’ve seen," said Dr. Hayley Gans of Stanford University Medical Center.
HHS Secretary Alex Azar said Wednesday that the...